Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis.
María Isabel Moreno-GambínJosé I TemblMiguel MazónAntonio José Cañada-MartínezLuis Martí-BonmatíTeresa SevillaJuan Francisco Vázquez CostaPublished in: Journal of neurology (2021)
In ALS patients, the absence of nigrosome 1 is associated with male sex, UMN impairment and shorter survival. This suggests that constitutional factors and the degree of pyramidal involvement are related to the substantia nigra involvement in ALS. Thus, nigrosome 1 could be a marker of a multisystem degeneration, which in turn associates to poor prognosis.